PhenX Toolkit: Toolkit

Essential Protocols

	Hydroxyurea Adherence - Prospective Studies THromboprophylaxis In Sickle cell disease with central venous catheters (THIS-1) Remove
	Acute Chest Syndrome - Pregnancy Malinowski AK, et al. Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data. Br J Haematol. 2021 Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme: Prospective Multi-Centre Cohort Study (SCOB-II). Check all Chest X-ray Add to Toolkit Remove
	Prophylactic Transfusion during Pregnancy Malinowski AK, et al. Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis. Blood. 2015 Oakley LL, et al. Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial. Trials. 2020 Remove
	Thromboprophylaxis Prophylactic Anticoagulation and central Venous access device-related thromboembolism In adult Sickle cell patients (PAVIS) Remove
	Thrombosis - Catheter-related Prophylactic Anticoagulation and central Venous access device-related thromboembolism In adult Sickle cell patients (PAVIS) Remove
	Thrombosis - Venous - non-catheter-related Cure Sickle Cell Initiative (CureSCi), F2909 Medical History Core Form, SCD Version 1.0 Remove
	Transfusion Indications Silent Cerebral Infarct Transfusion (SIT) Trial, S31r4 Transfusion Form Check all Gender Identity Hemoglobin Characterization Sex Assigned at Birth Add to Toolkit Remove
	Transfusion Reactions Silent Cerebral Infarct Transfusion (SIT) Trial, S32r0 Transfusion Reaction Form Check all Gender Identity Sex Assigned at Birth Add to Toolkit Remove
Total Protocols in My Toolkit: 8

Essential Protocols are needed to interpret your data. Add all Essential Protocols to your Toolkit.

My Toolkit